Mosquitoes; does anyone love them? No. They rank right up there with ticks, skunks, and moles. Not an attractive insect, but when it visits you, it leaves a visible, physical response in its quest to love you. No, we don’t love them, but do we need to eradicate them? Should we be changing its future? I am referencing a CNN article, Australian experiment wipes out over 80% of disease-carrying mosquitoes, By Jessie Yeung, CNN, that is speaking about experiments done in Australia. While I personally detest mosquitoes, I am unclear how I feel about the impact this might have on our eco-system. I only know it doesn’t feel right to me. I understand it will reduce disease in our species but what about the species who feed on the mosquitoes that have been genetically modified for our comfort and safety? I am concerned we are redirecting and changing the order of nature. Maybe we don’t care if mosquitoes become endangered. Maybe we pick and choose what gets to live because we are bigger and more evolved. Survival of the strongest and craftiest, or fittest? The article states this “shouldn’t” be a huge hit to the eco-system, because it’s only in one place now. All good until you realize that nothing attractive to others stays in that original place. We are rampantly spraying back yards with harsh chemicals to control the mosquitos in this country right now, with a full-on marketing campaign to support it. People truly detest mosquito bites. Therefore, it stands to reason when this genetic modification is shown to stop them, even where mosquito-borne diseases are minimal, there will be a bandwagon-style rush to reproduce it. We are currently contaminating our grass, trees, and the rest of the eco-system with chemicals to make mosquitoes only fly as close as your neighbor’s yard, so, hey, why not eradicate them? We aren’t worried about any impact 5, 10, or 50 years down the road anyway, are we? Where does it stop?
(Originally published in May 2018 Exposure Magazine)
Migraines are a common occurrence for many people. Women suffer them at a higher rate than men. According to the Food and Drug Administration, migraines are three times more common in women than in men and affects more than 10 percent of people worldwide. Drug therapies are super common and are very effective for some people. There are many options for treating migraines; however, drugs are the most common. There is a new drug, recently FDA approved, that has shown very promising results in several early clinical trials. It is considered a preventive drug rather than the traditional treatment drug. It is called Aimovig. This drug has been approved by the FDA for two types of migraine sufferers. It can be prescribed for episodic events, which are occurrences of zero to 14 days per month, and chronic events, which are 15 or more days per month. This drug focuses on preventing the migraine. There are quite a few other drugs in testing in this family of drugs for prevention as well, since the early studies are showing great success. This is great news for people who have migraines regularly. The only two side effects shown in the clinical trials were soreness at the injection site and constipation. This is probably a small price to pay for relief. Keep in mind that other common causes such as stress, sleep, specific foods in your diet, bright lights, etc. should be monitored and managed as well. Obviously, serious consideration should be given to controlling the factors that could be contributing along with any drug therapies. For more information on Aimovig, other therapies, and the clinical trials etc., visit FDA.gov.
These are my older blog posts, which originally appeared in my Exposure Magazine Column, "Healthy Living."